Summary
NF-κB transcription factors marshal innate and adaptive immunity and inflammation. NF-κB also counters programmed cell death (PCD) induced by the proinflammatory cytokine tumor necrosis factor (TNF)α, and this activity of NF-κB is crucial for organismal physiology, chronic inflammation, and tumorigenesis. Indeed, whereas NF-κB contributes to many aspects of oncogenesis, it is now clear that its suppressive action on PCD is central to this process. Notably, recent studies indicate that NF-κB represents a crucial link in the well-established association between inflammation and carcinogenesis. In this link, NF-κB promotes synthesis of inflammatory mediators (e.g. TNFα) that stimulate growth of cancer cells, and upregulates genes that protect these cells against PCD induced by inflammatory signals. Elevated NF-κB activity also hampers tumor-cell killing inflicted by radiation and chemotherapeutic drugs, and in so doing, promotes resistance to anticancer therapy. Accordingly, NF-κB-targeting drugs are increasingly being used for treatment of human malignancies. Owing to the ubiquitous nature of the NF-κB pathway, however, these drugs have serious side effects, which limit their clinical use. Thus, a preferable approach would be to block, rather than NF-κB itself, its critical downstream targets that mediate discrete functions in cancer, such as prosurvival functions. Recent discoveries unraveling tissue specificity in the NF-κB-inducible mechanism(s) for control of PCD and identifying putative effectors of this control clearly validate this therapeutic approach. Given the emerging role of TNFκ-induced signals of NF-κB activation in cancer and the potential of these signals for yielding new anticancer therapies, we focus herein on the methods most commonly used for analysis of the molecular steps leading from the triggering of TNF-Receptor (TNF-R)1 – the primary receptor of TNFα – to the induction of NF-κB. Specifically, we review the methods used for analysis of TNF-R1 trafficking, assembly of so-called TNF-R1 complex I, formation and activation of the IκB kinase (IKK) complex, phosphorylation and proteolysis of inhibitory IκB proteins, post-translational modifications and nuclear translocation of NF-κB dimers, induction of NF-κB transcriptional activity and binding to specific promoters, and upregulation of NF-κB target genes. The analysis of these events in cancerous cells may not only provide a better understanding of the basis for the role of NF-κB in carcinogenesis, but also potential new targets for selective anticancer therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hayden, M. S. and Ghosh, S. (2004) Signaling to NF-κB. Genes Dev. 18, 2195–2224
Papa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., and Franzoso, G. (2006) The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ. 14, 240–253
Basseres, D. S. and Baldwin, A. S. (2006) Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25, 6817–6830
Karin, M. (2006) Nuclear factor-κB in cancer development and progression. Nature 441, 431–436
Karin, M. and Greten, F. R. (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Immunol. 5, 749–759
Kim, H. J., Hawke, N., and Baldwin, A. S. (2006) NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 13, 738–747
Luo, J. L., Kamata, H., and Karin, M. (2005) IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy. J. Clin. Invest. 115, 2625–2632
Wajant, H., Pfizenmaier, K., and Scheurich, P. (2003) Tumor necrosis factor signaling. Cell Death Differ. 10, 45–65
Muppidi, J. R., Tschopp, J., and Siegel, R. M. (2004) Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21, 461–465
Micheau, O. and Tschopp, J. (2003) Induction of TNF receptor 1-mediated apoptosis via two sequential signalling complexes. Cell 114, 181–190
Schneider-Brachert, W., Tchikov, V., Neumeyer, J., Jakob, M., Winoto-Morbach, S., Held-Feindt, J., Heinrich, M., Merkel, O., Ehren-schwender, M., Adam, D., Mentlein, R., Kabelitz, D., and Schutze, S. (2004) Com-partmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signalling vesicles. Immunity 21, 415–428
Legler, D. F., Micheau, O., Doucey, M. A., Tschopp, J., and Bron, C. (2003) Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation. Immunity 18, 655–664
Sebban, H., Yamaoka, S., and Courtois, G. (2006) Posttranslational modifications of NEMO and its partners in NF-κB signaling. Trends Cell. Biol. 16, 569–577
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1987) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, US
Mauro, C, Pacifico, F., Lavorgna, A., Mellone, S., Iannetti, A., Acquaviva, R., Formisano, S., Vito, P., and Leonardi, A. (2006) ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J. Biol. Chem. 281, 18482–18488
Ea, C. K., Deng, L., Xia, Z. P., Pineda, G., and Chen, Z. J. (2006) Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245–257
Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M., and Ashwell, J. D. (2006) Sensing of lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell. Biol. 8, 398–406
Shambharkar, P. B., Marzenna, B., Pappu, B. P., Li, H., You, Y., Sakurai, H., Darnay, B. G., Hara, H., Penninger, J., and Lin, X. (2007) Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signalling pathways. EMBO J. 26, 1794–1805
Chen, Z. J., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. (1995) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586–1597
Franzoso, G., Biswas, P., Poli, G., Carlson, L. M., Brown, K D., Tomita-Yamaguchi, M., Fauci, A. S., and Siebenlist, U. K (1994) A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-κB subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells. J. Exp. Med. 180, 1445–1456
Jamaluddin, M., Wang, S., Boldogh, I., Tian, B., and Brasier, A. R. (2007) TNFα-induced NF-κB/RelA Ser276 phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell. Signal. 19, 1419–1433
Zhou, A., Scoggin, S., Gaynor, R B., and Williams N. S. (2003) Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference. Oncogene 22, 2054–2064
Acknowledgments
This work was supported in part by NIH grants CA084040 and CA098583 to G.F. C.M. is supported in part by a fellowship from the “Fondazione Italiana per la Ricerca sul Cancro” (FIRC). C.B. is supported in part by a fellowship from the American–Italian Cancer Foundation (AICF).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this protocol
Cite this protocol
Mauro, C., Zazzeroni, F., Papa, S., Bubici, C., Franzoso, G. (2009). The NF-κB Transcription Factor Pathway as a Therapeutic Target in Cancer: Methods for Detection of NF-κB Activity. In: Kozlov, S.V. (eds) Inflammation and Cancer. Methods in Molecular Biology™, vol 512. Humana Press. https://doi.org/10.1007/978-1-60327-530-9_10
Download citation
DOI: https://doi.org/10.1007/978-1-60327-530-9_10
Publisher Name: Humana Press
Print ISBN: 978-1-60327-529-3
Online ISBN: 978-1-60327-530-9
eBook Packages: Springer Protocols